GMED (Globus Medical) Tariff Resilience Score: 6/10 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMED Globus Medical Inc GMED
96 GF Score
Price $77.00
GF Value $98.78
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Tariff Resilience Score?

Globus Medical GMED -4.83% 96 Tariff Resilience Score is 6 as of Jul. 18, 2026. GuruFocus rates GMED with a GF Score™ of 96/100 and a GF Value™ of $98.78 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 834 Medical Devices & Instruments companies, Globus Medical ranks better than 91.01% on this metric.

Globus Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Globus Medical has Globus Medical's exposure to tariffs is moderate, with a global supply chain but significant US manufacturing. The medical device industry has some tariff exemptions, and the company can leverage alternative suppliers. Historical impacts have been manageable.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Globus Medical might have Average Resilient.

Globus Medical  (NYSE:GMED) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Globus Medical Tariff Resilience Score Related Terms

GMED vs PEN, PODD, BRKR: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Globus Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Globus Medical Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Globus Medical's Tariff Resilience Score falls into.


GMED
96GF Score
Globus Medical Inc GMED
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Globus Medical (GMED) has a Tariff Resilience Score of 6 as of Jul. 18, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Globus Medical ranks #75 out of 834 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Globus Medical's Tariff Resilience Score too high?
Globus Medical's current Tariff Resilience Score is 6. Based on the distribution chart, Globus Medical ranks #75 out of 834 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Tariff Resilience Score compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #75 out of 834 companies for Tariff Resilience Score. This places Globus Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Globus Medical's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.78, compared to a current price of $77.00 — trading 22% below its estimated fair value. The current Tariff Resilience Score is 6. Globus Medical's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Globus Medical (GMED), the current Tariff Resilience Score is 6 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of $77.00 is trading 22% below its estimated GF Value™ of $98.78. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for GMED:

  • Tariff Resilience Score: 6
  • GF Value™: $98.78 vs. price of $77.00 (22% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Globus Medical Business Description

Other Exchanges GMED:MexicoGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
96GF Score

Get the complete analysis for GMED

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$77.00
Price
$98.78
GF Value